JP1710114S - - Google Patents

Info

Publication number
JP1710114S
JP1710114S JP2021026079F JP2021026079F JP1710114S JP 1710114 S JP1710114 S JP 1710114S JP 2021026079 F JP2021026079 F JP 2021026079F JP 2021026079 F JP2021026079 F JP 2021026079F JP 1710114 S JP1710114 S JP 1710114S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021026079F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP2021026079F priority Critical patent/JP1710114S/ja
Application granted granted Critical
Publication of JP1710114S publication Critical patent/JP1710114S/ja
Priority to CA213011F priority patent/CA213011S/en
Priority to US29/840,145 priority patent/USD1011250S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021026079F 2021-11-29 2021-11-29 Active JP1710114S (Direct)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021026079F JP1710114S (Direct) 2021-11-29 2021-11-29
CA213011F CA213011S (en) 2021-11-29 2022-05-26 Instrument panel for an automobile
US29/840,145 USD1011250S1 (en) 2021-11-29 2022-05-26 Instrument panel for an automobile

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2021026079F JP1710114S (Direct) 2021-11-29 2021-11-29

Publications (1)

Publication Number Publication Date
JP1710114S true JP1710114S (Direct) 2022-03-17

Family

ID=80630879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021026079F Active JP1710114S (Direct) 2021-11-29 2021-11-29

Country Status (3)

Country Link
US (1) USD1011250S1 (Direct)
JP (1) JP1710114S (Direct)
CA (1) CA213011S (Direct)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD319614S (en) * 1989-08-08 1991-09-03 Fleetwood Enterprises, Inc. Motorhome dashboard
USD378585S (en) * 1995-03-07 1997-03-25 Navistar International Transportation Corp. Vehicle instrument panel
USD413095S (en) * 1997-12-10 1999-08-24 Navistar International Transportation Corp. Vehicle instrument panel
USD439556S1 (en) * 1999-11-17 2001-03-27 Navistar International Transportation Corp Instrument panel of a truck vehicle
USD718200S1 (en) * 2012-04-02 2014-11-25 Fisker Automotive And Technology Group Llc Vehicle interior
JP1530582S (Direct) * 2014-09-24 2018-07-30
JP1561330S (Direct) * 2016-04-12 2017-01-23
USD803120S1 (en) * 2016-10-13 2017-11-21 Fca Us Llc Automobile interior
USD841544S1 (en) * 2016-11-11 2019-02-26 Jaguar Land Rover Limited Interior panel for a vehicle
JP1590416S (Direct) * 2017-04-24 2018-11-05
JP1602618S (Direct) * 2017-06-30 2018-10-15
USD908569S1 (en) * 2018-11-06 2021-01-26 Polestar Performance Ab Instrument panel
JP1648399S (Direct) * 2019-04-01 2020-03-16

Also Published As

Publication number Publication date
CA213011S (en) 2023-12-22
USD1011250S1 (en) 2024-01-16

Similar Documents

Publication Publication Date Title
BR102021007058A2 (Direct)
BR102020022030A2 (Direct)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134275A1 (es) Anticuerpos cd24
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134206A1 (es) Degradantes y usos de los mismos
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos